Bharat Biotech ramps up Covaxin production capacity

To support vaccination campaigns in India and across the globe, Bharat Biotech has ramped up the manufacturing capacity of its Covid-19 vaccine, Covaxin, to 700 million doses per annum, the vaccine maker said on Tuesday.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3nackOn